Nanjing Hicin Pharmaceutical Co Ltd (300584) — Strategic Asset Allocation Index
Nanjing Hicin Pharmaceutical Co Ltd (300584) has a Strategic Asset Allocation Index of 58.7% as of June 2023. Strategic assets (PP&E of CN¥569.89 Million plus long-term investments of CN¥-) total CN¥569.89 Million, measured against net assets of CN¥970.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Nanjing Hicin Pharmaceutical Co Ltd Strategic Asset Allocation Index (2012–2022)
This chart shows how Nanjing Hicin Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 58.7%, representing strategic assets of CN¥569.89 Million against net assets of CN¥970.16 Million CNY. Explore Nanjing Hicin Pharmaceutical Co Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Nanjing Hicin Pharmaceutical Co Ltd (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 300584 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 53.2% | CN¥505.53 Million | CN¥505.53 Million | CN¥- | CN¥950.57 Million | ▲ +14.1 pp |
| 2021 | 39.1% | CN¥370.75 Million | CN¥370.75 Million | CN¥- | CN¥948.48 Million | ▼ -6.7 pp |
| 2020 | 45.8% | CN¥310.81 Million | CN¥310.81 Million | CN¥- | CN¥678.97 Million | ▼ -2.2 pp |
| 2019 | 48.0% | CN¥313.84 Million | CN¥313.84 Million | CN¥- | CN¥653.98 Million | ▼ -30.2 pp |
| 2018 | 78.2% | CN¥454.14 Million | CN¥323.87 Million | CN¥130.28 Million | CN¥580.93 Million | ▲ +24.3 pp |
| 2017 | 53.9% | CN¥278.83 Million | CN¥278.03 Million | CN¥800.00K | CN¥517.68 Million | ▼ -27.1 pp |
| 2016 | 80.9% | CN¥223.49 Million | CN¥223.49 Million | CN¥- | CN¥276.11 Million | ▲ +5.4 pp |
| 2015 | 75.6% | CN¥177.63 Million | CN¥177.63 Million | CN¥- | CN¥235.08 Million | ▼ -0.3 pp |
| 2014 | 75.9% | CN¥151.93 Million | CN¥151.93 Million | CN¥- | CN¥200.15 Million | ▼ -3.9 pp |
| 2013 | 79.8% | CN¥132.47 Million | CN¥132.47 Million | CN¥- | CN¥165.93 Million | ▲ +23.8 pp |
| 2012 | 56.0% | CN¥74.33 Million | CN¥74.33 Million | CN¥- | CN¥132.65 Million | — |